These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 948958)

  • 21. A general method for characterization of humoral immunity induced by a vaccine or infection.
    Legutki JB; Magee DM; Stafford P; Johnston SA
    Vaccine; 2010 Jun; 28(28):4529-37. PubMed ID: 20450869
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The immune response to influenza vaccines.
    Ghendon Y
    Acta Virol; 1990 May; 34(3):295-304. PubMed ID: 1980401
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influenza virus immunization. Antibody response and adverse effects in children with renal disease.
    Sheth KJ; Freeman ME; Eisenberg C; Sedmak GV
    JAMA; 1978 Jun; 239(24):2559-61. PubMed ID: 660787
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Anti-influenza immunity and the prediction of influenza morbidity in the upcoming epidemic season].
    Slepushkin AN; Fedorova GI; Popova NS; Mel'nichenko EI
    Vopr Virusol; 1983; (3):290-2. PubMed ID: 6604366
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Antineuraminidase serum antibodies in natural influenza A and immunization with influenza vaccines].
    Naĭkhin AN; Tsaritsyna IM; Syrodoeva LG; Oleĭnikova EV; Gorev NE
    Vopr Virusol; 1983; (2):154-9. PubMed ID: 6868553
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunity following intranasal administration of an inactivated, freeze-dried A/England/42/72 vaccine.
    Potter CW; Jennings R; McLaren C; Clarke A
    Arch Virol; 1975; 48(4):307-16. PubMed ID: 1200844
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Duration of circulating and secretory antibody and cell-mediated immunity following immunization.
    Waldman RH; Ganguly R
    Dev Biol Stand; 1975; 28():273-84. PubMed ID: 1126572
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytotoxic T-cell immunity to influenza.
    McMichael AJ; Gotch FM; Noble GR; Beare PA
    N Engl J Med; 1983 Jul; 309(1):13-7. PubMed ID: 6602294
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Hong Kong influenza immunity three years after immunization.
    Foy HM; Cooney MK; McMahan R
    JAMA; 1973 Nov; 226(7):758-61. PubMed ID: 4800628
    [No Abstract]   [Full Text] [Related]  

  • 30. The effect of cigarette smoking on susceptibility to epidemic influenza and on serological responses to live attenuated and killed subunit influenza vaccines.
    MacKenzie JS; MacKenzie IH; Holt PG
    J Hyg (Lond); 1976 Dec; 77(3):409-17. PubMed ID: 1069819
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunization with baculovirus displayed H6 hemagglutinin vaccine protects mice against lethal H6 influenza virus challenge.
    Musthaq SK; Kumar SR; Szyporta M; Kwang J
    Antiviral Res; 2014 Sep; 109():42-53. PubMed ID: 24973759
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparison of live and inactivated influenza A (H1N1) virus vaccines. 1. Short-term immunity.
    Clark A; Potter CW; Jennings R; Nicholl JP; Langrick AF; Schild GC; Wood JM; Tyrrell DA
    J Hyg (Lond); 1983 Jun; 90(3):351-9. PubMed ID: 6863909
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibodies against swine influenza virus neutralize the pandemic influenza virus A/H1N1.
    Tsukamoto M; Hiroi S; Adachi K; Kato H; Inai M; Konishi I; Tanaka M; Yamamoto R; Sawa M; Handharyani E; Tsukamoto Y
    Mol Med Rep; 2011; 4(2):209-14. PubMed ID: 21468553
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative trial of influenza vaccines. I. Immunogenicity of whole virus and split product vaccines in man.
    Barry DW; Mayner RE; Staton E; Dunlap RC; Rastogi SC; Hannah JE; Blackburn RJ; Nortman DF; Graze PR
    Am J Epidemiol; 1976 Jul; 104(1):34-46. PubMed ID: 947145
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aluminum interrupts the formation of alkaline-ribonuclease-inhibitor complex from bovine brain.
    Cho SW; Kim GY
    Eur J Biochem; 1991 Nov; 202(1):107-11. PubMed ID: 1935968
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Different protection rates in various groups of volunteers given subunit influenza virus vaccine in 1976.
    Feery BJ; Evered MG; Morrison EI
    J Infect Dis; 1979 Feb; 139(2):237-41. PubMed ID: 374644
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Parenteral influenza vaccination influences mucosal and systemic T cell-mediated immunity in healthy adults.
    Guthrie T; Hobbs CG; Davenport V; Horton RE; Heyderman RS; Williams NA
    J Infect Dis; 2004 Dec; 190(11):1927-35. PubMed ID: 15529256
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Characteristics of the immunological response in children to the administration of a live tissue-culture influenza vaccine].
    Unanov SS; Iuminova NV
    Vopr Virusol; 1982; 27(3):301-5. PubMed ID: 7123911
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Characteristics of immunity in influenza].
    Zilişteanu E; Creţescu L; Maţepiuc
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol; 1975; 20(3):137-46. PubMed ID: 128102
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influenza Virus Hemagglutinin Stalk-Specific Antibodies in Human Serum are a Surrogate Marker for
    Jacobsen H; Rajendran M; Choi A; Sjursen H; Brokstad KA; Cox RJ; Palese P; Krammer F; Nachbagauer R
    mBio; 2017 Sep; 8(5):. PubMed ID: 28928215
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.